.png){kind=icon}
返回
Gout
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(21)00569-9.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Gout is a common and treatable disease caused by the deposition of monosodium urate crystals in articular and non-articular structures. Increased concentration of serum urate (hyperuricaemia) is the most important risk factor for the development of gout. Serum urate is regulated by urate transporters in the kidney and gut, particularly GLUT9 (SLC2A9), URAT1 (SLC22A12), and ABCG2. Activation of the NLRP3 inflammasome by monosodium urate crystals with release of IL-1 beta plays a major role in the initiation of the gout flare; aggregated neutrophil extracellular traps are important in the resolution phase. Although presenting as an intermittent flaring condition, gout is a chronic disease. Long-term urate lowering therapy (eg, allopurinol) leads to the dissolution of monosodium urate crystals, ultimately resulting in the prevention of gout flares and tophi and in improved quality of life. Strategies such as nurse-led care are effective in delivering high-quality gout care and lead to major improvements in patient outcomes.
Keyword:
SERUM URIC-ACID
RANDOMIZED CONTROLLED-TRIAL
PURINE-RICH FOODS
DOUBLE-BLIND
MONOSODIUM URATE
RECURRENT GOUT
AMERICAN-COLLEGE
TOPHACEOUS GOUT
ASYMPTOMATIC HYPERURICEMIA
HYPERSENSITIVITY SYNDROME
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
分享收藏NPT1/SLC17A1 Is a Renal Urate Exporter in Humans and Its Common Gain-of-Function Variant Decreases the Risk of Renal Underexcretion Gout.png)
ARTHRITIS & RHEUMATOLOGY
ARTHRITIS & RHEUMATOLOGYIF10.9
PREAI
分享收藏HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinolHla-b * 5801等位基因作为别嘌呤醇所致严重皮肤不良反应的遗传标记
OAAI
OAAI分享收藏
查看更多内容